Striking a Balance: The Role of Glucagon Agonism to Improve Obesity and Metabolic Care

Gain in-depth knowledge on the current evidence supporting glucagon agonism to improve obesity and metabolic care, as well as the pathophysiologic mechanisms that connect obesity with certain comorbidities, through a downloadable “living” slideset, expert-authored ClinicalThought commentary, and on-demand webcast.

Share

Program Content

Activities

Obesity Glucagon Agonism
Striking a Balance: The Role of Glucagon Agonism to Improve Obesity and Metabolic Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 19, 2024

Expires: June 18, 2025

Faculty

cover img faculity

Jaime Almandoz, MD, MBA, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Domenica M. Rubino, MD

Director
Washington Center for Weight Management and Research
Arlington, Virginia

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company